U.S. Attorney General Pam Bondi has dropped the federal case against Utah doctor Michael Kirk Moore Jr., who was accused of issuing fake COVID-19 vaccine certificates and discarding over $28,000 worth of government-provided vaccines. Moore, a Salt Lake County plastic surgeon, faced charges after a 2023 federal indictment, but his trial was halted earlier this month.
Bondi announced the decision Saturday on X, stating Moore "did not deserve the years in prison he was facing" and had "given his patients a choice when the federal government refused to do so." The move has sparked heated debate, especially among vaccine skeptics and political allies of former President Donald Trump.
Moore allegedly operated the scheme from his clinic, giving saline shots to minors at their parents’ request so they would believe they were vaccinated, according to a 2023 statement from the U.S. Attorney’s Office in Utah.
The decision to drop the case was praised by conservative figures. Marjorie Taylor Greene, a Trump ally, called Moore a “hero” and said, “We can never again allow our government to turn tyrannical.” Health Secretary Robert F. Kennedy Jr., known for his vaccine skepticism, praised Moore’s actions on X, claiming he deserved “a medal for his courage.”
The case’s dismissal comes amid growing scrutiny of Bondi's recent removal of Justice Department officials who were investigating Trump, raising concerns over potential political retaliation within the department.
This high-profile case underscores the continued politicization of COVID-19 vaccine policies in the U.S., where public health, personal freedom, and federal authority remain deeply contested issues.


Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors
Trump Family Files $10 Billion Lawsuit Over IRS Tax Disclosure
Trump Signs Executive Order Threatening 25% Tariffs on Countries Trading With Iran
US Judge Rejects $2.36B Penalty Bid Against Google in Privacy Data Case
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate
Federal Judge Restores Funding for Gateway Rail Tunnel Project
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Japan Election 2026: Sanae Takaichi Poised for Landslide Win Despite Record Snowfall
Federal Reserve Faces Subpoena Delay Amid Investigation Into Chair Jerome Powell
Ghislaine Maxwell to Invoke Fifth Amendment at House Oversight Committee Deposition
Jack Lang Resigns as Head of Arab World Institute Amid Epstein Controversy
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
U.S. Lawmakers to Review Unredacted Jeffrey Epstein DOJ Files Starting Monday
Federal Judge Signals Possible Dismissal of xAI Lawsuit Against OpenAI 



